Navigation Links
Hand Washing with 4% CHG Antiseptic Kills Flu Viruses
Date:6/24/2009

Study shows 4% CHG antiseptic is effective against a strain of H1N1 Swine Flu

NORCROSS, Ga., June 24 /PRNewswire/ -- Hand washing with a 4% chlorhexidine gluconate (CHG) antiseptic hand washing product is one effective way to stop the spread of the H1N1 Swine Flu Virus.

Hibiclens Antiseptic/Antimicrobial Skin Cleanser and Hibistat Healthcare Personnel Hand Antiseptic Towelettes have been tested and found to be effective against a variation of the A H1N1 Swine Flu Virus, when used according to package instructions. The strain tested was Swine Flu Influenza A H1N1 A/Swine/Iowa/15/3.

The time-kill study, conducted by an independent laboratory showed that Hibiclens(R), a 4% CHG product, reduced the virus by 99.94 percent after 30 second, 60 second, and three minute exposures. Hibistat(R), a 0.5% CHG and 70% isopropyl alcohol formulation, reduced the virus by 99.99 percent after 15 second, 30 second and 60 second exposures. Both Hibiclens and Hibistat were more effective than soap and water which was used as a comparator test product.

"With any type of influenza outbreak, managing the spread of virus is the biggest concern," said Carolyn Twomey, RN, Global Head of Clinical Services, Molnlycke Health Care. "Influenza viruses usually spread via sneezing and coughing and contaminating one's hand or hands, and then touching surfaces, shaking hands or other contact behaviors. With any influenza outbreak, good hand hygiene is extremely important. With the current strains of flu virus, this study shows that washing with Hibiclens or using Hibistat Hand Wipes provides additional benefit in preventing transmission."

"Use of Molnlycke Health Care's Hibiclens and Hibistat antimicrobial/antiseptic products, along with the company's line of surgical facemasks and respirators, can be an integral part of a protocol to reduce the risk of cross-contamination," Twomey said.

Hibiclens is an antimicrobial/antiseptic cleanser that kills germs on contact and bonds with the skin to keep killing microorganisms for up to six hours without leaving a residue. The same cleanser combined with alcohol is available in convenient Hibistat(R) towelettes. Both are available at drug stores and pharmacies in the first aid section. For more information about Hibiclens, Hibistat or CHG, visit www.hibigeebies.com.

About Molnlycke Health Care US, LLC

Molnlycke Health Care US, LLC, consists of two divisions - Surgical and Wound Care. Focusing on prevention of surgically-related infections for both patients and healthcare workers, the Surgical Division (formerly Regent Medical Americas, LLC) encompasses the world's leading manufacturer and supplier of powder-free surgical gloves (Biogel(R) surgical gloves); the number one supplier (by value) of skin cleanser (Hibiclens(R) and Hibistat(R) antiseptics); and BARRIER(R) protective clothing. A leader in trauma and pain management, the Wound Care Division's market dynamics are driven by an aging population, higher incidence of pressure ulcers and increased home treatment.


'/>"/>
SOURCE Molnlycke Health Care
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Gene Found Activated in 70% of Prostate Cancer Cases, George Washington University Medical Center Scientists Report
2. Anpath Group, Inc. Advances Relationship With the Washington Metropolitan Area Transit Authority (Metro)
3. Whatcom County, Washington Participating in NIH Study of Cardiac Arrest Resuscitation Techniques
4. Resurgent Health and Medical Announces That Childrens Hospitals and Clinics of Minnesota has Ordered 25 CleanTech Automated Handwashing Systems
5. MedNet Solutions to Sponsor and Exhibit at the 2008 Advanced Medical Technology Association Conference in Washington, D.C.
6. CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCytes Glycoprotein Products in Heart Attack Disease Model
7. Alseres Pharmaceuticals, Inc. to Address a Congressional Briefing on Paralysis Research and the Spinal Cord Injury Community at Working 2 Walk in Washington, DC, April 13-15, 2008
8. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
9. DuPont Provides Technology for Washington Hospital Centers Emergency Department
10. Top Washington Health Officials to Honor Framingham Heart Study Participants
11. Anpath Group, Inc. Announces Selection of its Disinfectant by the Washington Metropolitan Area Transit Authority (Metro)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology:
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):